Koninklijke Philips N.V.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Roy W. O. Jakobs
- Full Time Employees
- 66,401
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Philips Center Amsterdam NH Netherlands 1077 WV
- IPO Date
- Mar 17, 1980
- CIK
- 0000313216
- Website
- philips.ca
- Similar Companies
- Business
- Koninklijke Philips N.V. is a global health technology company headquartered in Amsterdam, Netherlands, founded in 1891. It operates mainly across the diagnosis and treatment, connected care, and personal health segments, offering a broad range of products and services including precision diagnostic imaging systems, image-guided therapy solutions, patient monitoring devices, health informatics, respiratory care, and personal health and home care products. Its core portfolio features advanced diagnostic imaging devices such as CT and ultrasound systems, AI-enabled clinical decision support tools, enterprise health informatics platforms, sleep and respiratory care solutions, and consumer health categories including grooming and oral healthcare devices. Philips serves markets primarily in North America, Western Europe, Greater China, and other growth geographies. Recent developments include the launch of the AI-powered Philips CT 5300 system, integrating advanced hardware and software with artificial intelligence to enhance imaging quality and boost clinical workflow efficiency. This system offers ultra-low dose screening capabilities and improved diagnostic confidence with smart workflow automation. Philips has also introduced two FDA-cleared AI applications for its Lumify point-of-care ultrasound system, enabling smarter, faster frontline care in anesthesia, emergency medicine, and critical care. Strategically, Philips has maintained cost discipline, restructuring its supply chain and reducing overhead while investing selectively in innovation projects. The company reported a reduced M&A spend in 2023 compared to 2022, focusing on operational improvements and cash preservation. Philips’ business model is arranged into global, end-to-end business units—Diagnosis & Treatment, Connected Care, and Personal Health—each managing their operations independently. Notably, the company is investing in improving productivity and operational efficiency with multi-year savings programs and enhanced product pipeline focus. Its recent partnerships include collaborations with healthcare institutions such as Hôpital Fondation Rothschild in Paris and Erasmus University Medical Center. Philips aims to improve 2.5 billion lives annually by 2030, reflecting its strategic commitment to health technology innovation and broad accessibility. Financially, Philips generated approximately $19.5 billion in revenue in 2024, employing around 67,800 people globally. The company continues to navigate challenges such as supply chain disruptions and market demand fluctuations, particularly in China, while driving growth in mature markets and leveraging AI and digital technologies to reinforce its competitive position in healthcare technology. Its leadership in diagnostic imaging, patient monitoring, connected care, and personal health makes it a key player in the global health technology industry.
Company News
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
Philips Oral Healthcare Establishes Global Clinical Advisory Board to Help Shape the Future of Oral Care Through Scientific and Clinical Insight
Koninklijke Philips N.V. (NYSE:PHG) Given Average Rating of “Hold” by Brokerages
Southwest Mississippi Regional Medical Center Becomes First U.S. Hospital to Install Philips Rembra CT for Acute and High-Demand Imaging Environments
Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
Philips OneBlade and Red Bull take self-expression to new heights in Cappadocia, Turkey
Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
Philips advances women's health ultrasound with new single-transducer solution
Financial Analysis: Koninklijke Philips (NYSE:PHG) & Microbot Medical (NASDAQ:MBOT)
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
Philips prices EU green bond for EUR 650M
Bank of America Corp DE Purchases 50,124 Shares of Koninklijke Philips N.V. $PHG
Philips, Shell targeted by hacking group
Agnelli family's Exor can raise Philips stake to 22% under updated agreement
Exor and Philips Extend Long-term Relationship Agreement
Cetera Investment Advisers Acquires 45,968 Shares of Koninklijke Philips N.V. $PHG